SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001610717-24-000191
Filing Date
2024-03-29
Accepted
2024-03-29 16:16:24
Documents
2
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 3319
2 poa.htm EX-24 20058
  Complete submission text file 0001610717-24-000191.txt   24750
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 171 FOREST LN. MENLO PARK CA 94025
Business Address
Easom Eric (Reporting) CIK: 0001914503 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41331 | Film No.: 24804299